216 related articles for article (PubMed ID: 33212223)
1. CD36 in Alzheimer's Disease: An Overview of Molecular Mechanisms and Therapeutic Targeting.
Dobri AM; Dudău M; Enciu AM; Hinescu ME
Neuroscience; 2021 Jan; 453():301-311. PubMed ID: 33212223
[TBL] [Abstract][Full Text] [Related]
2. CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils.
Coraci IS; Husemann J; Berman JW; Hulette C; Dufour JH; Campanella GK; Luster AD; Silverstein SC; El-Khoury JB
Am J Pathol; 2002 Jan; 160(1):101-12. PubMed ID: 11786404
[TBL] [Abstract][Full Text] [Related]
3. Identification of Inhibitors of CD36-Amyloid Beta Binding as Potential Agents for Alzheimer's Disease.
Doens D; Valiente PA; Mfuh AM; X T Vo A; Tristan A; Carreño L; Quijada M; Nguyen VT; Perry G; Larionov OV; Lleonart R; Fernández PL
ACS Chem Neurosci; 2017 Jun; 8(6):1232-1241. PubMed ID: 28150942
[TBL] [Abstract][Full Text] [Related]
4. CD36 upregulation mediated by intranasal LV-NRF2 treatment mitigates hypoxia-induced progression of Alzheimer's-like pathogenesis.
Wang CY; Wang ZY; Xie JW; Cai JH; Wang T; Xu Y; Wang X; An L
Antioxid Redox Signal; 2014 Dec; 21(16):2208-30. PubMed ID: 24702189
[TBL] [Abstract][Full Text] [Related]
5. SELENOK-dependent CD36 palmitoylation regulates microglial functions and Aβ phagocytosis.
Ouyang P; Cai Z; Peng J; Lin S; Chen X; Chen C; Feng Z; Wang L; Song G; Zhang Z
Redox Biol; 2024 Apr; 70():103064. PubMed ID: 38320455
[TBL] [Abstract][Full Text] [Related]
6. IL-4-induced selective clearance of oligomeric beta-amyloid peptide(1-42) by rat primary type 2 microglia.
Shimizu E; Kawahara K; Kajizono M; Sawada M; Nakayama H
J Immunol; 2008 Nov; 181(9):6503-13. PubMed ID: 18941241
[TBL] [Abstract][Full Text] [Related]
7. CD36 mediates the innate host response to beta-amyloid.
El Khoury JB; Moore KJ; Means TK; Leung J; Terada K; Toft M; Freeman MW; Luster AD
J Exp Med; 2003 Jun; 197(12):1657-66. PubMed ID: 12796468
[TBL] [Abstract][Full Text] [Related]
8. Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease.
Koronyo-Hamaoui M; Sheyn J; Hayden EY; Li S; Fuchs DT; Regis GC; Lopes DHJ; Black KL; Bernstein KE; Teplow DB; Fuchs S; Koronyo Y; Rentsendorj A
Brain; 2020 Jan; 143(1):336-358. PubMed ID: 31794021
[TBL] [Abstract][Full Text] [Related]
9. A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid.
Moore KJ; El Khoury J; Medeiros LA; Terada K; Geula C; Luster AD; Freeman MW
J Biol Chem; 2002 Dec; 277(49):47373-9. PubMed ID: 12239221
[TBL] [Abstract][Full Text] [Related]
10. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
11. Microglial Aβ receptors in Alzheimer's disease.
Yu Y; Ye RD
Cell Mol Neurobiol; 2015 Jan; 35(1):71-83. PubMed ID: 25149075
[TBL] [Abstract][Full Text] [Related]
12. Effects of IL-34 on Macrophage Immunological Profile in Response to Alzheimer's-Related Aβ
Zuroff LR; Torbati T; Hart NJ; Fuchs DT; Sheyn J; Rentsendorj A; Koronyo Y; Hayden EY; Teplow DB; Black KL; Koronyo-Hamaoui M
Front Immunol; 2020; 11():1449. PubMed ID: 32765504
[TBL] [Abstract][Full Text] [Related]
13. A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation.
Bamberger ME; Harris ME; McDonald DR; Husemann J; Landreth GE
J Neurosci; 2003 Apr; 23(7):2665-74. PubMed ID: 12684452
[TBL] [Abstract][Full Text] [Related]
14. The age-related microglial transformation in Alzheimer's disease pathogenesis.
Yuan C; Aierken A; Xie Z; Li N; Zhao J; Qing H
Neurobiol Aging; 2020 Aug; 92():82-91. PubMed ID: 32408056
[TBL] [Abstract][Full Text] [Related]
15. DW14006 as a direct AMPKα1 activator improves pathology of AD model mice by regulating microglial phagocytosis and neuroinflammation.
Lv J; Wang W; Zhu X; Xu X; Yan Q; Lu J; Shi X; Wang Z; Zhou J; Huang X; Wang J; Duan W; Shen X
Brain Behav Immun; 2020 Nov; 90():55-69. PubMed ID: 32739363
[TBL] [Abstract][Full Text] [Related]
16. beta-Amyloid promotes accumulation of lipid peroxides by inhibiting CD36-mediated clearance of oxidized lipoproteins.
Kunjathoor VV; Tseng AA; Medeiros LA; Khan T; Moore KJ
J Neuroinflammation; 2004 Nov; 1(1):23. PubMed ID: 15546489
[TBL] [Abstract][Full Text] [Related]
17. Desacyl-ghrelin and synthetic GH-secretagogues modulate the production of inflammatory cytokines in mouse microglia cells stimulated by beta-amyloid fibrils.
Bulgarelli I; Tamiazzo L; Bresciani E; Rapetti D; Caporali S; Lattuada D; Locatelli V; Torsello A
J Neurosci Res; 2009 Sep; 87(12):2718-27. PubMed ID: 19382238
[TBL] [Abstract][Full Text] [Related]
18. Nogo receptor impairs the clearance of fibril amyloid-β by microglia and accelerates Alzheimer's-like disease progression.
Wang J; Qin X; Sun H; He M; Lv Q; Gao C; He X; Liao H
Aging Cell; 2021 Dec; 20(12):e13515. PubMed ID: 34821024
[TBL] [Abstract][Full Text] [Related]
19. PPARγ/RXRα-induced and CD36-mediated microglial amyloid-β phagocytosis results in cognitive improvement in amyloid precursor protein/presenilin 1 mice.
Yamanaka M; Ishikawa T; Griep A; Axt D; Kummer MP; Heneka MT
J Neurosci; 2012 Nov; 32(48):17321-31. PubMed ID: 23197723
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2 receptor subtype 2 regulation of scavenger receptor CD36 modulates microglial Aβ42 phagocytosis.
Li X; Melief E; Postupna N; Montine KS; Keene CD; Montine TJ
Am J Pathol; 2015 Jan; 185(1):230-9. PubMed ID: 25452117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
